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Abstract 23 
Passive heat stress increases core and skin temperatures and reduces tolerance to simulated 24 
hemorrhage (lower body negative pressure; LBNP). We tested whether exercise induced heat 25 
stress reduces LBNP tolerance to a greater extent relative to passive heat stress, when skin 26 
and core temperatures are similar. Eight participants (6 males, 32±7 yrs, 176±8 cm, 77.0±9.8 27 
kg) underwent LBNP to pre-syncope on three separate and randomized occasions: 1) passive 28 
heat stress, 2) exercise in a hot environment (40°C) where skin temperature was moderate 29 
(36°C, Active 36), and 3) exercise in a hot environment (40°C) where skin temperature was 30 
matched relative to that achieved during passive heat stress (~38°C, Active 38). LBNP 31 
tolerance was quantified using the cumulative stress index (CSI).  Prior to LBNP, increases in 32 
core temperature from baseline were not different between trials (1.18±0.20°C; P>0.05). Also 33 
prior to LBNP, mean skin temperature was similar between passive heat stress (38.2±0.5°C) 34 
and Active 38 (38.2±0.8°C; P = 0.90) trials, while it was reduced in the Active 36 trial 35 
(36.6±0.5°C; P≤0.05 compared to passive heat stress and Active 38). LBNP tolerance was 36 
not different between passive heat stress and Active 38 trials (383±223 and 322±178 CSI, 37 
respectively; P=0.12) but both were similarly reduced relative to Active 36 (516±147 CSI, 38 
both P≤0.05). LBNP tolerance is not different between heat stresses induced either passively 39 
or by exercise in a hot environment when skin temperatures are similarly elevated. However 40 
LBNP tolerance is influenced by the magnitude of the elevation in skin temperature 41 
following exercise induced heat stress. 42 
  43 
3 
 
Introduction 44 
Passive heat stress increases core and skin temperatures, and is accompanied with profound 45 
reductions in tolerance to central hypovolemia (e.g., lower body negative pressure -LBNP),  46 
that simulates a hemorrhagic state (2, 26, 29, 31, 48, 51). This is due, in part, to a large 47 
displacement of blood to the cutaneous circulation and associated reductions in systemic 48 
vascular resistance (42) and central blood volume (12, 13), coupled with inadequate 49 
cutaneous vasoconstriction during the hypotensive challenge (11, 38). Such tolerance is 50 
likewise reduced following short-term exercise in a thermoneutral environment that is not 51 
accompanied by profound increases in skin and core temperatures (6). This response may be 52 
due to post-exercise reductions in baroreflex sensitivity (40, 49), lowered arterial blood 53 
pressure (9, 16, 27, 39) and an impaired transduction of sympathetic outflow into 54 
vasoconstriction (20) coupled with elevations in vascular conductance in the previously 55 
active limb (34).  56 
Blood pressure and vascular alterations following exercise may be exacerbated if the exercise 57 
is performed under hot environmental conditions owing to heighted skin and core 58 
temperatures, as well as elevated limb muscle and skin vascular conductances (34, 36, 41, 44, 59 
50). Such a response may reduce tolerance to a simulated hemorrhagic challenge to a greater 60 
extent relative to a passive heat stress, when increases in core and skin temperatures are 61 
similar.  To that end, the first objective of this project was to test the hypothesis that tolerance 62 
to a simulated hemorrhagic challenge (via LBNP) is lower following exercise in a hot 63 
environment relative to a similar thermal provocation induced by passive heat stress.  64 
Skin temperatures following passive heat stress can markedly affect tolerance to a subsequent 65 
hypotensive challenge, with cooler skin improving this tolerance (52). It remains unknown 66 
whether skin temperature following an exercise heat stress likewise affects tolerance to such 67 
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a challenge. To this end, the second objective of this study was to test the hypothesis that 68 
tolerance to a simulated hemorrhagic challenge following exercise in a hot environment is 69 
influenced by skin temperature. The obtained information has direct implications for the 70 
understanding of blood pressure control in a soldier who may be heat stressed passively (e.g., 71 
turret gunner, sniper, etc.) or actively (e.g., foot patrol) and experiences a subsequent 72 
hemorrhagic injury.   73 
 74 
  75 
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Methods 76 
Subjects 77 
Eight subjects (six males) participated in this study. Subject characteristics were; age 32 ± 7 78 
years; height, 176 ± 8 cm; weight 77.0 ± 9.8 kg; peak oxygen uptake (VO2 peak) 43.6 ± 8 79 
ml/kg/min; and peak power output 262 ± 33 watts (mean ± SD). Women were tested in the 80 
follicular phase of the menstrual cycle or the placebo phase if they were taking birth control 81 
pills. Subjects were not taking medications (aside from birth control pills), were non-82 
smokers, were free of any known cardiovascular, metabolic, or neurological diseases and 83 
refrained from alcohol, caffeine, and exercise for 24 h before the study. Subjects were 84 
informed of the purpose, procedures and risks of the study before providing their informed 85 
written consent. The protocol and consent were approved by the Institutional Review Boards 86 
at the University of Texas Southwestern Medical Center at Dallas and Texas Health 87 
Presbyterian Hospital Dallas. 88 
Instrumentation and Experimental Protocol 89 
In preparation for experimental days, subjects completed a graded exercise test on a cycle 90 
ergometer (Lode, Groningen, Netherlands) in thermoneutral conditions. Power output was 91 
recorded from the cycle ergometer while oxygen uptake, including peak, was measured using 92 
standard indirect calorimetry procedures (Parvo Medics' TrueOne® 2400, Utah, USA). 93 
On experimental days, ~2 hours prior to the onset of data collection, subjects swallowed an 94 
ingestible telemetry pill for the measurement of core temperature from intestinal temperature 95 
(HQ, Palmetto, Florida). Subjects voided their bladder before nude body mass was recorded.  96 
Adequate hydration was confirmed via urine specific gravity (<1.028) which was measured 97 
using a digital refractometer. Height was measured using a stadiometer. 98 
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Mean skin temperature was measured from the weighted average temperature across six sites 99 
(Taylor et al., 1989) using thermocouples fixed to the skin with porous adhesive tape. Arterial 100 
blood pressure was continuously measured non-invasively using photoplethysmography 101 
(Finometer Pro, FMS, Amsterdam, Netherlands), which was used to calculate mean arterial 102 
pressure. Heart rate was obtained from an electrocardiogram (ECG, Agilent, Munich, 103 
Germany) that was interfaced with a cardiotachometer (1000 Hz sampling rate, CWE, 104 
Ardmore, PA, USA). Following instrumentation, subjects rested in the supine position for 30 105 
minutes to allow for the stabilization of fluid shifts.  Baseline data were subsequently 106 
obtained.   107 
Subjects were then exposed to three randomized and counterbalanced trials separated by at 108 
least 3 days. During one trial, each subject donned a water-perfused tube lined suit (Med-109 
Eng, Ottawa, Canada) that covered their entire body except for the head, hands and feet. The 110 
suit permitted the control of whole-body skin and internal temperatures by adjusting the 111 
temperature of the water perfusing the suit. Subjects were exposed to whole-body heating by 112 
perfusing 48-50°C water through the suit to elevate core temperature by ~1.2°C (Passive). 113 
During the other two trials, subjects exercised on an upright cycle ergometer at 50% of their 114 
predetermined peak power output in an environmental chamber set to 40°C and 30% relative 115 
humidity until core temperature increased by ~1.2°C. After achieving the desired increase in 116 
core temperature, the subject rapidly donned the aforementioned water perfused suit. The 117 
temperature of the water perfusing the suit was adjusted such that mean skin temperature was 118 
clamped at ~36.5°C to match skin temperature at the end of exercise (i.e., Active 36) or 119 
clamped at ~38.0°C to match skin temperature during the passive heat stress trial (i.e., Active 120 
38). These two trials (Active 36 and Active 38) were designed to address the influence of 121 
skin temperature upon LBNP tolerance following exercise induced heat stress. Given the 122 
influence of heighted skin temperatures in compromising cutaneous vasoconstriction to 123 
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LBNP (11, 38), clamping skin temperature in the Active 38 trial was an important control 124 
measure to ensure appropriate comparison with the passive heat stress trial.  125 
Participants were encouraged to ingest 7 ml/kg body mass of warm water (37.1 ± 1.2°C) in 126 
all trials during the thermal provocation prior to LBNP. The volume of water ingested during 127 
the passive heat stress trial (403 ± 238 mL) was slightly less than the volume ingested in both 128 
Active 36 and Active 38 trials (551 ± 264 and 575 ± 256mL respectively, both P ≤ 0.05) 129 
while fluid ingestion was not different between Active 36 and Active 38 trials (P > 0.05).  130 
In all trials, following the desired increase in core and mean skin temperatures, subjects 131 
underwent a supine LBNP tolerance test to the onset of pre-syncope.  LBNP began at 20 132 
mmHg for 3 min, followed by increasing negative pressure by 10 mmHg in 3 min stages until 133 
pre-syncope. The termination of LBNP was based upon subject self-reporting of feeling faint 134 
and/or nauseous, a rapid and progressive decrease in blood pressure resulting in sustained 135 
systolic blood pressure being ≤80 mmHg, and/or a relative and pronounced bradycardia. 136 
Throughout LBNP, arterial blood pressures were also measured at the brachial artery by 137 
auscultation (Tango, Suntech Medical Instruments, Raleigh, NC, USA). Tolerance to LBNP 138 
was quantified using the cumulative stress index (CSI) (33), calculated by summing the time 139 
at each level of LBNP multiplied by that level (i.e., 20 mmHg * 3 min + 30 mmHg * 3 min + 140 
40 mmHg * 3 min, etc.) until pre-syncope. Nude body mass was obtained prior to any 141 
provocation and following the LBNP tolerance test.  142 
Data Analysis 143 
Temperature and hemodynamic data were collected via a data-acquisition system (Biopac 144 
System, Santa Barbara, CA). Data were averaged across 60 seconds at baseline and after the 145 
desired increase in core and mean skin temperatures prior to LBNP. During LBNP, data were 146 
averaged over a 30 second period immediately preceding 20%, 40%, 60% and 80% of the 147 
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maximal CSI, and also during the 15 seconds immediately preceding the termination of 148 
LBNP (i.e. pre-syncope). Data were statistically analyzed using a two-way analysis of 149 
variance with repeated measures, with main factors of thermal condition (levels: Passive, 150 
Active 36, Active 38) and time (levels: baseline, pre-LBNP, 20%, 40%, 60%, 80% max CSI, 151 
and pre-syncope). For CSI, data were analyzed via one way repeated measures ANOVA 152 
across the three perturbations.  Post-hoc analyses were performed using paired t-tests with a 153 
bonferroni correction when a significant main effect or interaction was identified. Data are 154 
reported as mean ± SD.    155 
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Results 156 
Cardiovascular and temperature variables were not different at baseline between trials (Table 157 
1). Mean skin temperature was elevated from baseline due to both passive and active heat 158 
stress perturbations prior to LBNP (all P ≤ 0.05 within trials relative to baseline, Fig. 1). Prior 159 
to LBNP, mean skin temperatures were not different between passive heat stress and Active 160 
38 trials, but both were higher relative to the Active 36 trial (both P ≤ 0.05). Core temperature 161 
increased in all trials (P ≤ 0.05), with this measure  not being different between trials 162 
immediately prior to LBNP.  Relative to baseline, heart rate increased and blood pressure 163 
decreased at pre-LBNP in all trials (all P ≤ 0.05), but both the absolute and the change in 164 
these measures to the heating stimuli were not different between trials (Fig. 2).   165 
The duration of passive heat stress (39 ± 9 min) prior to achieving a 1.2 °C increase in core 166 
temperature was shorter than the exercise duration in both Active 36 and Active 38 trials (48 167 
± 11 and 47 ± 12 min, respectively, both P ≤ 0.05 relative to passive heat stress), while 168 
exercise time was not different between Active 36 and Active 38 trials (P > 0.05). The 169 
magnitude of the reduction in body mass was not different between trials (Passive: 1.1 ± 0.3, 170 
Active 36: 1.4 ± 0.7 and Active 38: 1.4 ± 0.5 kg, respectively, P > 0.05). 171 
Regardless of the trial, mean skin temperature did not change during LBNP (Fig. 1).  172 
However, during this period core temperature increased ~0.3°C in the passive and Active 38 173 
trials (P ≤ 0.05) but did not change in the Active 36 trial (Table 1).  During LBNP heart rate 174 
increased relative to baseline (P ≤ 0.05), but then declined from 80% CSI to pre-syncope in 175 
all trials (P ≤ 0.05, Fig. 2). Arterial blood pressure declined in all trials during LBNP through 176 
pre-syncope (P ≤ 0.05), with the magnitude of this reduction not being different between 177 
trials.  Despite differing modes of heating, LBNP tolerance was not different between passive 178 
heat stress (340 ± 204 CSI units) and Active 38 (346 ± 167 CSI units, P = 0.119) trials, while 179 
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LBNP tolerance during the Active 36 trial (513 ± 188 CSI units) was greater relative to both 180 
passive and Active 38 trials (P ≤ 0.05, Fig. 3). The lower LBNP tolerance in the Active 38 181 
trial relative to the Active 36 trial was evident in seven out of eight subjects; with difference 182 
in tolerance of 201 ± 95 CSI units. In the one subject where LBNP tolerance was not reduced 183 
in the Active 38 relative to the Active 36 trial, LBNP tolerance was 313 and 241 CSI units 184 
respectively.  185 
11 
 
Discussion 186 
Given that both passive heat stress (2, 26, 29, 31, 48, 51) and exercise in a thermoneutral 187 
environment (6) impair tolerance to a hypotensive challenge, we hypothesized that the 188 
combination of exercise in the heat would further reduce LBNP tolerance, relative to passive 189 
heat stress alone, when controlling for internal and mean skin temperatures.  Counter to that 190 
hypothesis, LBNP tolerance was not different between these two perturbations when mean 191 
skin temperatures were clamped at similar levels.  A secondary objective tested the 192 
hypothesis that mean skin temperature influences LBNP tolerance following exercise in a hot 193 
environment.  Consistent with that hypothesis, LBNP tolerance following exercise in the heat 194 
was influenced by the magnitude of the elevation in mean skin temperature.  195 
During a simulated hemorrhagic challenge, such as LBNP, central blood volume is reduced 196 
and the drive for neurally-mediated vasoconstriction increases (5, 18, 43, 45). Given that skin 197 
and muscle vascular conductance increase in hyperthermic humans (22, 30, 35, 37, 42), the 198 
ability to vasoconstrict appropriately in these vascular beds is important for blood pressure 199 
control during a subsequent hypotensive challenge. Vascular control is impaired following 200 
exercise in thermoneutral conditions (i.e., in the absence of appreciable increases in core 201 
and/or skin temperatures) (19, 34), evidenced by a reduction in baroreflex sensitivity (40, 49) 202 
and mean arterial pressure (34), a reduced transduction of sympathetic outflow into vascular 203 
resistance, and lower sympathetic outflow for any given blood pressure (20). Consistent with 204 
these responses, orthostatic tolerance is impaired following a short term bout of exercise in a 205 
thermoneutral environment (6). Passive heat stress places a significant burden on the 206 
cardiovascular system, which in part is due to pronounced increases in systemic vascular 207 
conductance (42) and reductions in central blood volume (13). Vascular control is impaired 208 
following passive heat stress through a decreased vasoconstrictor responsiveness to 209 
reductions in central blood volume (11). Given the influences of passive heat stress and 210 
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exercise in altering vascular control via unique mechanisms, we expected an additive effect 211 
resulting in lower tolerance to LBNP following exercise in a hot environment, relative to 212 
passive heat stress, when controlling for the elevation in core and skin temperatures.  213 
However, counter to that hypothesis, LBNP tolerance was not different between passive heat 214 
stress and active 38 trials (Fig. 3).  215 
The lack of difference in LBNP tolerance between these two trials may be explained by two 216 
possibilities. First, it is possible that increases in muscle vascular conductance associated with 217 
dynamic exercise decreased to levels similar to passive heat stress (22, 30, 37) during the 218 
period between the cessation of exercise and the onset of LBNP (14.7 ± 3.4 min). However, 219 
femoral vascular conductance remains elevated for up to 90 min following cycling exercise in 220 
a warm environment (34). It is therefore unlikely that exercise induced elevations in leg 221 
vascular conductance had completely returned to baseline values prior to the onset of LBNP. 222 
Second, a more likely explanation is that similar increases in cutaneous vascular conductance, 223 
owing to similar increases in mean skin temperature (1, 4, 25), between the passive heat 224 
stress and Active 38 trials contributed to comparable LBNP tolerances. This argument is 225 
strengthened by findings that such elevations in mean skin temperature and cutaneous 226 
vascular conductance are associated with an inadequate cutaneous vasoconstrictor response 227 
(38), which contributes to reduced tolerance to LBNP (11).  Therefore, the present results 228 
suggest that LBNP tolerance is more closely related to the elevation in mean skin temperature 229 
rather than the methodology of increasing core temperature (e.g., passive vs. exercise-230 
induced), and that vascular responses post-exercise do not have an additive effect in 231 
contributing to compromised tolerance to central hypovolemia. Thus, exercise itself does not 232 
further compromise tolerance to a simulated hemorrhagic challenge relative to passive heat 233 
stress, when elevations in mean skin temperature are similar between conditions.   234 
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LBNP tolerance was attenuated in the Active 38 trial relative to the Active 36 trial. The most 235 
likely explanation for this observation is the difference in mean skin temperature between 236 
these trials, which affected tolerance perhaps via two unique mechanisms.  First, the extent of 237 
cutaneous vasodilation under the water perfused suit, and thus presumably the reduction in 238 
central blood volume (13) before LBNP, would be greater in the Active 38 trial relative to the 239 
Active 36 trial. Consistent with this hypothesis, decreasing mean skin temperature by actively 240 
cooling the skin of otherwise hyperthermic individuals increases central blood volume and 241 
greatly improves tolerance to an orthostatic stress (14, 52).  Second, elevated skin 242 
temperatures attenuate cutaneous vasoconstrictor responses to a hypotensive challenge (38), 243 
perhaps through nitric oxide mechanisms (15, 24, 46, 47, 53).  The extent of cutaneous 244 
vasoconstriction at pre-syncope via LBNP is greatly attenuated in skin heated to 38°C 245 
relative to skin heated to 35°C (38).  Therefore, differences in LBNP tolerance between 246 
Active 38 and Active 36 may be due, in part, to both: A) local temperature-induced 247 
differences in the magnitude of cutaneous vasodilation prior to LBNP and B) differences in 248 
the extent of cutaneous vasoconstriction under the water perfused suit during LBNP between 249 
trials.  Those mechanisms aside, throughout LBNP core temperature slightly increased in the 250 
Active 38 trial (~ Δ0.3°C) but was unchanged in the Active 36 trial.  One may propose that 251 
such differences in core temperature could have contributed to the observed differences in 252 
LBNP tolerance. However, the magnitude of increase in core temperature during heat stress, 253 
between ~ Δ0.9 – 1.8°C, is not associated with differences in LBNP tolerance (17). It is 254 
therefore unlikely that a relatively small difference in core temperature during LBNP in the 255 
Active 38 trial contributed to reduced LBNP tolerance relative to the Active 36 trial; rather 256 
such tolerance differences were likely attributed to differences in skin temperature.  257 
Limitations and considerations to the interpretation of the findings 258 
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The present study did not include a normothermic LBNP challenge.  Such a challenge was 259 
not necessary to address the proposed hypotheses, and thus inclusion of a normothermic 260 
LBNP challenge would expose subjects to an unnecessary procedure and therefore some level 261 
of risk.  That said, using a similar LBNP ramp, as well as CSI criteria to evaluate LBNP 262 
tolerance, we consistently observe CSI mean values in the ~900-1100 mmHg×min range in 263 
normothermic subjects (7, 28, 29, 32), which is well above what was observed in any of the 264 
three trials in the present experiment. 265 
In Active 36 and 38 trials, after obtaining the appropriate increase in core temperature, 266 
participants donned the water perfused suit for the control of skin temperature and were 267 
transferred into position for LBNP. The duration of this process varied between ~ 8 - 15 268 
minutes. Despite this time delay, exercise induced alterations in baroreflex sensitivity (40, 269 
49), blood pressure (16, 21), sympathetic nerve activity (20) and limb blood flow (34) are 270 
evident for at least 60 minutes after the cessation exercise. It is therefore unlikely that the 271 
influence of exercise induced neural and cardiovascular alterations upon LBNP tolerance 272 
diminished due to this period between the cessation of exercise and the onset of LBNP.  273 
The duration of the heat stress perturbation was not different between Active 36 and 38 trials 274 
but was lower in the passive heat stress trial. Methodologically, it may have been more 275 
appropriate to clamp the heat stress duration between trials, though this would be very 276 
challenging given a variety of factors that influence the rate of heating during passive heat 277 
stress (e.g., size of the individual, water temperature and perfusion rate of the suit, etc), 278 
resulting in multiple passive heat stress trials to achieve a desired temperature within a 279 
specified duration. Nevertheless, there is currently no evidence to suggest that the duration of 280 
heat stress per se is a significant contributor to LBNP tolerance.  However, it is recognized 281 
that longer heating periods may lead to more pronounced dehydration, which could influence 282 
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LBNP tolerance yet in the present protocol the reduction in body mass (i.e, fluid loss) was 283 
similar between trials  284 
In both Active trials subjects exercised at an intensity equal to 50% of their peak power 285 
output.  This workload was selected for two reasons: 1) it is a similar intensity to that 286 
commonly occurring during routine military foot/reconnaissance patrols (3, 23), and 2) it is a 287 
workload that can be maintained for sufficient period of time in relatively non-trained 288 
subjects to achieve the desired increases in core temperature. While it may be insightful to 289 
identify the combined influence of heat stress and exercise at substantially higher (or even 290 
maximal) intensities on LBNP tolerance, the subjects may not have been able to tolerate the 291 
workload for a sufficient duration to achieve the required increases in core temperature.  That 292 
said, the responses observed in the present observation should not be extrapolated to what 293 
may occur following high intensity exercise in hot environmental conditions. 294 
Perspectives and significance  295 
These data have implications for individuals who become hyperthermic through either 296 
passive heat stress or exercise, and who are at risk for a hemorrhagic injury, such as 297 
firefighters and soldiers. For example, military personnel are often deployed in warm 298 
environments where they are exposed to both passive (i.e., snipers, turret gunners, etc.) and 299 
active heat stresses (i.e., foot patrols) while wearing body armor. Buller et al reported 300 
comparable increases in both skin and core temperatures during military procedures in Iraq 301 
relative to the present observations (8). The present data indicate that the implications of a 302 
hemorrhagic injury are similarly dire between actively and passively heat stressed 303 
individuals, when skin temperatures are equally elevated.  Furthermore, given that LBNP 304 
tolerance was prolonged following active heat stress when mean skin temperature was ~2°C 305 
lower, reducing skin temperature of hyperthermic and hemorrhaging individuals could prove 306 
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beneficial towards survival. This small reduction in skin temperature may be achieved 307 
without cooling the skin with ice or related modalities.  Therefore, identification of a light 308 
weight non-ice dependent cooling modality to decrease skin temperature ~2°C may be 309 
beneficial in the treatment of a hemorrhaging hyperthermic soldier in the pre-hospital setting.  310 
Finally, it is noteworthy that soldiers are currently warmed following a hemorrhagic injury 311 
(10).  Based upon the present findings, this action may actually be harmful for the soldier 312 
who is not hypothermic, as recently proposed (10).    313 
Conclusions 314 
The present results show that tolerance to a simulated hemorrhagic challenge resulting in 315 
central hypovolemia and accompanying hypotension is not different between actively and 316 
passively heat stressed individuals, when internal and mean skin temperatures are controlled 317 
for.  Second, during active heat stress resulting in comparable increases in internal 318 
temperatures, relatively small differences in mean skin temperature can appreciably affect 319 
tolerance to a hypotensive challenge.  These data suggest that exercise itself does not further 320 
decrease tolerance to a simulated hemorrhagic challenge when compared to passive heat 321 
stress, which may have important implications towards the treatment of a hyperthermic 322 
individual who has experienced a hemorrhagic injury.   323 
 324 
 325 
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Figure Legends 468 
Figure 1: Core and skin temperatures prior to and during LBNP to pre-syncope in all 469 
conditions.  470 
Mean skin and core body temperatures increased with all methods of heat stress prior to 471 
LBNP. However, by design, mean skin temperatures were higher following passive heat 472 
stress and Active 38 trials when compared to Active 36 (both P ≤ 0.05), and remained higher 473 
throughout LBNP to pre-syncope. At pre-syncope, mean skin temperature was unchanged (P 474 
> 0.05) while core temperature was slightly elevated in the passive heat stress and Active 38 475 
trials. Data are mean ± SD at baseline, immediately prior to LBNP (pre-LBNP), throughout 476 
LBNP at 20, 40, 60 and 80% of maximal CSI and at pre-syncope.* Different from baseline in 477 
all trials (P ≤ 0.05). # Different from pre-LBNP in passive heat stress and Active 38 trials 478 
only (P ≤ 0.05). λ Different from Active 36 (P ≤ 0.05). 479 
Figure 2: Heart rate and blood pressure responses prior to and during LBNP to pre-480 
syncope in all conditions.  481 
When expressed relative to a percent of maximal CSI, heart rate and mean arterial pressure 482 
were not different between trials at any point. In all trials, blood pressure and heart rate 483 
decreased at pre-syncope relative to 80% CSI. Data are mean ± SD at baseline, immediately 484 
prior to LBNP (pre-LBNP), throughout LBNP at 20, 40, 60 and 80% of maximal CSI and at 485 
pre-syncope. * Different from baseline in all trials (P ≤ 0.05). § Different from 80% CSI in all 486 
trials (P ≤ 0.05).  487 
Figure 3: Cumulative stress index in all trials 488 
22 
 
Tolerance to simulated hemorrhage (expressed as cumulative stress index; CSI) was similarly 489 
reduced in passive heat stress and Active 38 trials relative to Active 36 (P ≤ 0.05). Data are 490 
mean ± SD. * Different from Active 36 (P ≤ 0.05).   491 
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Table 1: Thermal and hemodynamic measures during baseline, pre-LBNP, 80% CSI, and at pre-syncope for all three trials. 492 
 Passive Heat Stress Active 36 Active 38 
 Baseline Pre-
LBNP 
80% 
CSI 
Pre- 
syncope 
Baseline Pre-
LBNP 
80% 
CSI 
Pre- 
syncope 
Baseline Pre-
LBNP 
80% CSI Pre- 
syncope 
Tcore 
(°C) 
 
36.8 ±  
0.4 
38.0 ± 
0.4 * 
38.3 ± 
0.5 * #
38.3 ± 
0.5 * # 
37.0 ±  
0.3 
38.1 ± 
0.4 * 
38.1 ± 
0.4 * 
38.1 ± 
0.5 * 
36.9 ±  
0.3 
38.0 ± 
0.2 * 
38.3 ± 
0.3 * # 
38.3 ± 
0.3 * # 
Tsk 
(°C) 
 
32.9 ±  
0.7 
38.2 ± 
0.5 * 
37.9 ± 
0.6 * 
37.9 ± 
0.6 * 
33.2 ±  
1.4 
36.6 ± 
0.5 * λ 
36.4 ± 
0.4 * λ 
36.4 ± 
0.4 * λ 
33.4 ± 
 0.6 
38.2 ± 
0.7 * 
37.9 ± 
0.8 * 
38.0 ± 
0.8 * 
MAP 
(mmHg) 
 
82 ±  
8 
79 ±  
13 * 
71 ± 
16 * 
59 ±  
11 * § 
91 ±  
8 
75 ±  
8 * 
73 ±  
10 * 
56 ±  
13 * § 
91 ±  
7 
75 ±  
11 * 
70 ±  
6 * 
56 ±  
5 * § 
HR 
(bpm) 
53 ±  
8 
99 ±  
12 * 
140 ± 
15 * 
123 ±  
32 * § 
59 ±  
10 
101 ± 
14 * 
138 ± 
16 * 
129 ±  
16 * § 
58 ±  
10 
109 ± 
13 * 
145 ± 
 14 * 
136 ±  
14 * § 
Tcore, body core temperature; Tsk, mean skin temperature; MAP, mean arterial pressure; HR, heart rate. Values are means ± SD for 8 493 
participants. * Different from baseline within trial (P ≤ 0.05). # Different from Pre-LBNP within trial (P ≤ 0.05). λ Different from passive heat 494 
stress and active 38 trials (P ≤ 0.05). § Different from 80% CSI within trial (P ≤ 0.05)  495 
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